THE MKENA.COM DIARIES

CDER’s latest proposal to withdraw the accelerated acceptance of Makena (HPC) was centered upon a big randomized demo that failed to verify the advantage of this drug to newborns or decrease the chance of PTB. In earning the choice to suggest Makena’s withdrawal, CDER also reviewed final results from prior studies of progestins (HPC and vario